$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222023366 Filed on August 17, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$16.97K	$16.97K
YoY Change	103.51%	103.51%
Cost Of Revenue
YoY Change
Gross Profit	$16.97K	$16.97K
YoY Change	103.51%	103.51%
Gross Profit Margin	100.0%	100.0%
Selling, General & Admin	$533.0K	$1.512M	$1.364M
YoY Change	-4.44%	-18.16%	73.18%
% of Gross Profit	3140.48%	8909.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.24K	$13.37K	$13.10K
YoY Change	11.07%	13.4%	12.93%
% of Gross Profit	78.01%	78.77%
Operating Expenses	$533.0K	$1.512M	$1.364M
YoY Change	-4.44%	-18.16%	73.18%
Operating Profit	-$516.1K	-$1.495M	-$1.364M
YoY Change	-6.08%	-18.71%	73.18%
Interest Expense	$631.3K	$224.8K	-$145.5K
YoY Change	-427.82%	55.14%	-24.18%
% of Operating Profit
Other Income/Expense, Net	-$462.0K	-$365.3K
YoY Change	-561.99%	169.63%
Pretax Income	-$978.1K	-$1.861M	-$1.493M
YoY Change	52.33%	-5.79%	50.71%
Income Tax
% Of Pretax Income
Net Earnings	-$978.1K	-$1.861M	-$1.493M
YoY Change	52.33%	-5.79%	50.71%
Net Earnings / Revenue	-5762.4%	-10961.57%
Basic Earnings Per Share	-$0.03	-$0.05
Diluted Earnings Per Share	-$26.87K	-$52.48K	-$42.88K
COMMON SHARES
Basic Shares Outstanding	36.14M shares	35.45M shares
Diluted Shares Outstanding	36.39M shares	35.45M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.84K	$5.530K	$193.3K
YoY Change	-86.35%	-67.16%	60.31%
Cash & Equivalents	$95.84K	$5.534K
Short-Term Investments
Other Short-Term Assets	$206.1K	$202.7K	$223.9K
YoY Change	17.64%	-2.49%	-7.17%
Inventory
Prepaid Expenses
Receivables	$55.47K	$327.3K	$315.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$357.4K	$535.5K	$732.8K
YoY Change	-63.48%	138.34%	102.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.379M	$2.264M	$2.070M
YoY Change	33.99%	31.83%	28.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.280M	$2.330M	$2.471M
YoY Change	-16.15%	-13.29%
Other Assets	$647.4K	$647.4K	$647.4K
YoY Change	-6.24%	-5.09%	-3.92%
Total Long-Term Assets	$5.699M	$5.348M	$5.293M
YoY Change	9.92%	5.15%	131.89%
TOTAL ASSETS
Total Short-Term Assets	$357.4K	$535.5K	$732.8K
Total Long-Term Assets	$5.699M	$5.348M	$5.293M
Total Assets	$6.057M	$5.884M	$6.026M
YoY Change	-1.74%	10.78%	127.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.780M	$1.588M	$1.395M
YoY Change	72.02%	62.28%	61.53%
Accrued Expenses
YoY Change
Deferred Revenue	$487.5K	$330.4K
YoY Change
Short-Term Debt	$1.299M	$986.5K	$914.1K
YoY Change	52.08%	3.92%	40.51%
Long-Term Debt Due	$2.209M	$2.097M	$2.006M
YoY Change	2049.57%	409.69%	373.82%
Total Short-Term Liabilities	$6.054M	$5.022M	$4.470M
YoY Change	158.32%	88.49%	93.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.054M	$5.022M	$4.470M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.054M	$5.022M	$4.470M
YoY Change	48.85%	14.76%	11.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.00M	-$18.10M
YoY Change
Common Stock	$36.47K	$36.14K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$291.2K	$568.5K	$1.263M
YoY Change
Total Liabilities & Shareholders Equity	$6.057M	$5.884M	$6.026M
YoY Change	-1.74%	10.78%	127.88%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$978.1K	-$1.861M	-$1.493M
YoY Change	52.33%	-5.79%	50.71%
Depreciation, Depletion And Amortization	$13.24K	$13.37K	$13.10K
YoY Change	11.07%	13.4%	12.93%
Cash From Operating Activities	-$175.9K	$14.75K	-$344.9K
YoY Change	-48.02%	-107.3%	111.8%
INVESTING ACTIVITIES
Capital Expenditures	-$128.2K	-$207.3K	-$109.0K
YoY Change	83.14%	482.25%	-19.65%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$128.2K	-$207.3K	-$109.0K
YoY Change	-24.59%	52.89%	-19.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	394.4K	4.840K	590.6K
YoY Change	-66.96%	-97.93%	45.51%
NET CHANGE
Cash From Operating Activities	-175.9K	14.75K	-344.9K
Cash From Investing Activities	-128.2K	-207.3K	-109.0K
Cash From Financing Activities	394.4K	4.840K	590.6K
Net Change In Cash	90.31K	-187.7K	136.7K
YoY Change	-86.82%	81.0%	27.27%
FREE CASH FLOW
Cash From Operating Activities	-$175.9K	$14.75K	-$344.9K
Capital Expenditures	-$128.2K	-$207.3K	-$109.0K
Free Cash Flow	-$47.65K	$222.1K	-$235.9K
YoY Change	-82.24%	-233.32%	767.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	ILAL	Shares Issued With Debt Modification SharesIssuedWithDebtModification		usd
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeit Canceled Weighted Average Canceled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitCanceledWeightedAverageCanceled
	ILAL	Cancellation Of Previously Issued Common Stock CancellationOfPreviouslyIssuedCommonStock		usd
	ILAL	Interest On Notes Paid By Related Party InterestOnNotesPaidByRelatedParty		usd
	ILAL	Construction In Progress Paid By Related Party ConstructionInProgressPaidByRelatedParty		usd
	ILAL	Common Stock Issued As Consideration For Equitymethod Investee CommonStockIssuedAsConsiderationForEquitymethodInvestee		usd
	ILAL	Common Stock Issued In Settlement Of Related Party Accrued Interest On Note CommonStockIssuedInSettlementOfRelatedPartyAccruedInterestOnNote		usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermExercised
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing		usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001657214
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q1	ILAL	Stock Issued During Period Value From Plot Sale StockIssuedDuringPeriodValueFromPlotSale		usd
CY2021Q1	ILAL	Stock Issued During Period Value Issued For Services One StockIssuedDuringPeriodValueIssuedForServicesOne		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	ILAL	Expenses Paid By Related Party ExpensesPaidByRelatedParty		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash		usd
	ILAL	Common Stock Issued From Options Exercise CommonStockIssuedFromOptionsExercise		usd
	ILAL	Common Stock Warrants And Plots Promised For Cash Net CommonStockWarrantsAndPlotsPromisedForCashNet		usd
	ILAL	Cash Proceeds From Refinancing Net CashProceedsFromRefinancingNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes		usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement		usd
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermForfeited
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56111
	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL LAND ALLIANCE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3752361
	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 10th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92101
	dei	City Area Code CityAreaCode	(877)
	dei	Local Phone Number LocalPhoneNumber	661-4811
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36138029	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5534	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56590	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	327289	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	314090	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	202672	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	251665	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	535495	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	622345	usd
CY2022Q2	us-gaap	Land Land	203419	usd
CY2021Q4	us-gaap	Land Land	203419	usd
CY2022Q2	us-gaap	Land Available For Sale LandAvailableForSale	647399	usd
CY2021Q4	us-gaap	Land Available For Sale LandAvailableForSale	647399	usd
CY2022Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	889948	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	915884	usd
CY2022Q2	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	2146	usd
CY2021Q4	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	2682	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1168355	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	852020	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
CY2022Q2	ILAL	Accrued Interest On Note Receivable AccruedInterestOnNoteReceivable	7180	usd
CY2021Q4	ILAL	Accrued Interest On Note Receivable AccruedInterestOnNoteReceivable	3234	usd
CY2022Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2329737	usd
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2511830	usd
CY2022Q2	us-gaap	Assets Assets	5883679	usd
CY2021Q4	us-gaap	Assets Assets	5858813	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1587511	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1656533	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	330433	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	126663	usd
CY2022Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	20000	usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	20000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2097316	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	102762	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	986447	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	834984	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5021707	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2740942	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1735538	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5021707	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4476480	usd
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36138029	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36138029	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31849327	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31849327	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	36139	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31850	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18589351	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15760772	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18057047	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14703818	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5883679	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5858813	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16973	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8340	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	33946	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17559	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	16973	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	8340	usd
	us-gaap	Gross Profit GrossProfit	33946	usd
	us-gaap	Gross Profit GrossProfit	17559	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	772405	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1198300	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	802683	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1215200	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	739801	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	649398	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2073747	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1420245	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1512206	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1847698	usd
	us-gaap	Operating Expenses OperatingExpenses	2876430	usd
	us-gaap	Operating Expenses OperatingExpenses	2635445	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1495233	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1839358	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2842484	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2617886	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	536	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2499	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	536	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8377	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-140989	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6942	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-182093	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6942	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	224821	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	144913	usd
	us-gaap	Interest Expense InterestExpense	329188	usd
	us-gaap	Interest Expense InterestExpense	345992	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-365274	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-135472	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-510745	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-347427	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1860507	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1974830	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3353229	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2965313	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35452918	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25975729	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34164313	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24743583	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q1	ILAL	Stock Issued During Period Shares Issued Pursuant To Promissory Notes StockIssuedDuringPeriodSharesIssuedPursuantToPromissoryNotes	202275	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	447278	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	871688	usd
CY2022Q1	ILAL	Stock Issued During Period With Warrant Issued In Connection With Debt Financing StockIssuedDuringPeriodWithWarrantIssuedInConnectionWithDebtFinancing	159664	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1492722	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1262616	usd
CY2022Q2	ILAL	Stock Issued During Period Value Stock Issued With Finders Fee Agreement StockIssuedDuringPeriodValueStockIssuedWithFindersFeeAgreement	40490	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	700	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	729885	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	410288	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1860507	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1201920	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	8970	usd
CY2021Q1	ILAL	Stock Issued During Period Value Commitment Shares Issued StockIssuedDuringPeriodValueCommitmentSharesIssued	130900	usd
CY2021Q1	ILAL	Stock Issued During Period Value Against Accrued Interest Due To Related Party StockIssuedDuringPeriodValueAgainstAccruedInterestDueToRelatedParty	10999	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	347380	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-990483	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-1664154	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	29521	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	100000	usd
CY2021Q2	ILAL	Stock Issued During Period Value Equity Method Investments StockIssuedDuringPeriodValueEquityMethodInvestments	2580000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000	usd
CY2021Q2	ILAL	Stock Issued During Period Value Pursuant To Consulting Agreements StockIssuedDuringPeriodValuePursuantToConsultingAgreements	259108	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1307078	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1974830	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	641723	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3353229	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2965313	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1281976	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1922536	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1177163	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10876	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26472	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23387	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-182093	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6942	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	144935	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	136975	usd
	ILAL	Expenses Paid By Related Party ExpensesPaidByRelatedParty	-25462	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13199	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-48993	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-124580	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-25219	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	215444	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	39	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3946	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	203770	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	30000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	117980	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-330191	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-365054	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	100000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	316335	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	171259	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-316335	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-271259	usd
	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash	65000	usd
	ILAL	Common Stock Issued From Options Exercise CommonStockIssuedFromOptionsExercise	1300	usd
	ILAL	Common Stock Warrants And Plots Promised For Cash Net CommonStockWarrantsAndPlotsPromisedForCashNet	100000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	192244	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	152543	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	51128	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	593196	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	522500	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	288874	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	315042	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	563112	usd
	ILAL	Cash Proceeds From Refinancing Net CashProceedsFromRefinancingNet	368736	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	595470	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	639983	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-51056	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3670	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56590	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13171	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5534	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16841	usd
	us-gaap	Interest Paid Net InterestPaidNet	75858	usd
	us-gaap	Interest Paid Net InterestPaidNet	75513	usd
	ILAL	Dividend On Series B DividendOnSeriesB	30000	usd
	ILAL	Dividend On Series B DividendOnSeriesB	30000	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	93700	usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement	40490	usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing	159664	usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote	28665	usd
	ILAL	Shares Issued With Debt Modification SharesIssuedWithDebtModification	8970	usd
	ILAL	Cancellation Of Previously Issued Common Stock CancellationOfPreviouslyIssuedCommonStock	315288	usd
	ILAL	Interest On Notes Paid By Related Party InterestOnNotesPaidByRelatedParty	11067	usd
	ILAL	Construction In Progress Paid By Related Party ConstructionInProgressPaidByRelatedParty	84614	usd
	ILAL	Common Stock Issued As Consideration For Equitymethod Investee CommonStockIssuedAsConsiderationForEquitymethodInvestee	2580000	usd
	ILAL	Commitment Shares Issued With Convertible Note CommitmentSharesIssuedWithConvertibleNote	202275	usd
	ILAL	Commitment Shares Issued With Convertible Note CommitmentSharesIssuedWithConvertibleNote	130900	usd
	ILAL	Common Stock Issued In Settlement Of Related Party Accrued Interest On Note CommonStockIssuedInSettlementOfRelatedPartyAccruedInterestOnNote	10999	usd
CY2022Q2	ILAL	Working Capital WorkingCapital	4500000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3353229	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18100000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-330000	usd
	us-gaap	Depreciation Depreciation	26472	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	2097316	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	1838300	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2097316	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	102762	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_ztsM3ChbPLg3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zUeHnICThwYe">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful life of buildings.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowances.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived asset for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Depreciation Depreciation	23387	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	1400000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	181300	usd
CY2022Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	15000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	30000	usd
	us-gaap	Advertising Expense AdvertisingExpense	802683	usd
	us-gaap	Advertising Expense AdvertisingExpense	39200	usd
CY2022Q2	ILAL	Notes Payable Gross NotesPayableGross	2459482	usd
CY2021Q4	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	362166	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	51462	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1735538	usd
	ILAL	Aggregate Interest Amount AggregateInterestAmount	71480	usd
CY2022Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.71
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding	P4Y7M9D
CY2022Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	3867500	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.80
CY2022Q2	ILAL	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Offering Percentage ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1OfferingPercentage	1.25	pure
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7717500	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3100000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zhFVZl0UiZY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zVxT4Vhm77Q3">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zN5bn1I1At4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zYBjvDJF0dnj">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to prior year’s data to confirm to the current year’s presentation. Such reclassifications had no impact on the Company’s financial condition, operating results, cash flows or stockholders’ deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2019Q1	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	1122050	usd
	us-gaap	Interest Expense Other InterestExpenseOther	30000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	158190	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132254	usd
CY2022Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	889948	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	915884	usd
	ILAL	Repayment Of Promissory From Related Parties RepaymentOfPromissoryFromRelatedParties	28870	usd
	ILAL	Commitment To Purchase Of Land CommitmentToPurchaseOfLand	The land project consisting
CY2022Q2	us-gaap	Area Of Land AreaOfLand	20
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36138029	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31849327	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	150000000	shares
	ILAL	Stock Issued During Period Shares Existing Finders Fee StockIssuedDuringPeriodSharesExistingFindersFee	88988	shares
	ILAL	Stock Issued During Period Values Existing Finders Fee StockIssuedDuringPeriodValuesExistingFindersFee	40490	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	65000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	140000	shares
CY2022Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3180000	shares
CY2021Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.69
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P5Y29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	687500	shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.80
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted	P4Y8M26D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3867500	shares
CY2022Q2	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2021Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3850000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1300000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.001
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P5Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1300000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.001
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1	P5Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3850000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M21D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3550000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	716000	usd

Files In Submission

Name	View Source	Status
0001493152-22-023366-index-headers.html	Edgar Link	pending
0001493152-22-023366-index.html	Edgar Link	pending
0001493152-22-023366.txt	Edgar Link	pending
0001493152-22-023366-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ilal-20220630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ilal-20220630_lab.xml	Edgar Link	unprocessable
ilal-20220630_pre.xml	Edgar Link	unprocessable
ilal-20220630_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ilal-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2022 Q3 Form 10-Q Financial Statement

#000149315222023366 Filed on August 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2022 Q3 Form 10-Q Financial Statement

#000149315222023366 Filed on August 17, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal